NCT04958720

Brief Summary

This study aims to development of a database through a web page for epidemiological and clinical research purposes that is accessible to members of the AGAMENON - SEOM group that guarantees a rigorous collection, exploitation and analysis of the data and information contained, increases the knowledge of esophageal and stomach cancer in order to optimize the management, treatment and evolution of patients, the possibility of comparing variables with those of other series or groups, and promotes the quality of scientific publications.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
117mo left

Started Apr 2020

Longer than P75 for all trials

Geographic Reach
1 country

38 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Apr 2020Dec 2035

Study Start

First participant enrolled

April 27, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 14, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

July 12, 2021

Completed
13.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2034

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2035

Last Updated

July 3, 2025

Status Verified

June 1, 2025

Enrollment Period

14.6 years

First QC Date

June 14, 2021

Last Update Submit

June 30, 2025

Conditions

Keywords

Gastric CancerGastroesophageal junction cancerEsophageal CancerSurgeryChemotherapyRadiotherapyAntitargeted drugInmunotherapy

Outcome Measures

Primary Outcomes (1)

  • Diagnostic and therapeutic approach

    To evaluate survival (time in months) according to treatment of esophagogastric cancer in all stages, patients, and contexts.

    Up to 12 months

Secondary Outcomes (8)

  • Epidemiological profiles

    Up to 12 months

  • Risk factors

    Up to 12 months

  • Pathological features

    Up to 12 months

  • Clinical and diagnostic approach

    Up to 12 months

  • Treatments adjusted to prognostic variables

    Up to 12 months

  • +3 more secondary outcomes

Study Arms (2)

Cohort 1

Resectable non-advanced cancer

Procedure: SurgeryDrug: Chemotherapy, anti-targeted agents and immunotherapyRadiation: Radiotherapy

Cohort 2

Unresectable advanced cancer

Procedure: SurgeryDrug: Chemotherapy, anti-targeted agents and immunotherapyRadiation: Radiotherapy

Interventions

SurgeryPROCEDURE

Surgery

Cohort 1Cohort 2

Chemotherapy, anti-targeted agents and immunotherapy

Cohort 1Cohort 2
RadiotherapyRADIATION

Radiotherapy

Cohort 1Cohort 2

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study plans to enroll patients with histologically confirmed carcinoma of the esophagus, gastroesophageal junction, and stomach. The inclusion of patients is required to be done consecutively, being valid any time point if data are available.

You may qualify if:

  • Adult patient (≥18 years) diagnosed with carcinoma of the esophagus, gastroesophageal junction and stomach, including all histologic subtypes, with or without erbB2 overexpression (and tumors in which this data is unknown).
  • Follow-up of at least 3 months with clinical information during this period, exempting patients with early death from any cause.

You may not qualify if:

  • A patient for whom, for whatever reason, the information necessary to complete the database cannot be known or obtained.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (38)

Hospital General Universitario de Alicante

Alicante, Alicante, 03010, Spain

RECRUITING

Hospital General Universitario de Elche

Elche, Alicante, 03203, Spain

RECRUITING

Hospital General Universitario de Elda

Elda, Alicante, 03600, Spain

RECRUITING

Hospital Universitario Reina Sofia

Córdoba, Andalusia, 14004, Spain

RECRUITING

Hospital Regional Universitario de Málaga

Málaga, Andalusia, 29010, Spain

RECRUITING

Hospital Universitario Virgen Macarena

Seville, Andalusia, 41009, Spain

RECRUITING

Hospital Universitario Virgen del Rocio

Seville, Andalusia, 41013, Spain

RECRUITING

Hospital Universitario Son Espases

Palma de Mallorca, Balearic Islands, 07120, Spain

RECRUITING

Hospital Son Llàtzer

Palma de Mallorca, Balearic Islands, 07198, Spain

RECRUITING

Hospital del Mar

Barcelona, Barcelona, 08003, Spain

RECRUITING

Hospital Universitario Vall d'Hebrón

Barcelona, Barcelona, 08035, Spain

RECRUITING

Hospital Clínic de Barcelona

Barcelona, Barcelona, 08036, Spain

RECRUITING

Hospital de la Santa Creu i Sant Pau

Barcelona, Barcelona, 08041, Spain

RECRUITING

Institut Català d'Oncologia

L'Hospitalet de Llobregat, Barcelona, 08908, Spain

RECRUITING

Hospital Universitari Parc Taulí

Sabadell, Barcelona, 08208, Spain

RECRUITING

Hospital Universitario Marques de Valdecillas

Santander, Cantabria, 39008, Spain

RECRUITING

Hospital General Universitario de Ciudad Real

Ciudad Real, Ciudad Real, 13005, Spain

RECRUITING

Hospital Universitario de Jaén

Jaén, Jaén, 23007, Spain

RECRUITING

Complejo Hospitalario Universitario de A Coruña

A Coruña, La Coruña, 15006, Spain

RECRUITING

Hospital San Pedro

Logroño, La Rioja, 26006, Spain

RECRUITING

Hospital Universitario Fundación Alcorcón

Alcorcón, Madrid, 28922, Spain

RECRUITING

Hospital General Universitario Gregorio Marañón

Madrid, Madrid, 28007, Spain

RECRUITING

Hospital Universitario Ramón y Cajal

Madrid, Madrid, 28034, Spain

RECRUITING

Hospital Clínico San Carlos

Madrid, Madrid, 28040, Spain

RECRUITING

Hospital Universitario 12 de Octubre

Madrid, Madrid, 28041, Spain

RECRUITING

Hospital Universitario La Paz

Madrid, Madrid, 28046, Spain

RECRUITING

Hospital Central de la Defensa Gómez Ulla

Madrid, Madrid, 28047, Spain

RECRUITING

Hospital General Universitario Santa Lucía

Cartagena, Murcia, 30202, Spain

RECRUITING

Hospital General Universitario Morales Meseguer

Murcia, Murcia, 30008, Spain

RECRUITING

Complejo Hospitalario Universitario de Ourense

Ourense, Ourense, 32005, Spain

RECRUITING

Hospital Universitario de Navarra

Pamplona, Pamplona, 31008, Spain

RECRUITING

Hospital Provincial de Pontevedra

Pontevedra, Pontevedra, 36002, Spain

RECRUITING

Hospital Universitario Central de Asturias

Oviedo, Principality of Asturias, 33011, Spain

RECRUITING

Complejo Asistencial Universitario de Salamanca

Salamanca, Salamanca, 37007, Spain

RECRUITING

Hospital Universitario de Canarias

San Cristóbal de La Laguna, Santa Cruz de Tenerife, 38320, Spain

RECRUITING

Hospital Universitario Nuestra Señora de la Candelaria

Santa Cruz de Tenerife, Santa Cruz de Tenerife, 38010, Spain

RECRUITING

Hospital General Universitario de Valencia

Valencia, Valencia, 46014, Spain

RECRUITING

Hospital Universitario de Galdakao

Galdakao, Vizcaya, 48960, Spain

RECRUITING

MeSH Terms

Conditions

Esophageal NeoplasmsStomach Neoplasms

Interventions

Surgical Procedures, OperativeDrug TherapyImmunotherapyRadiotherapy

Condition Hierarchy (Ancestors)

Gastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsDigestive System DiseasesEsophageal DiseasesGastrointestinal DiseasesStomach Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsImmunomodulationBiological Therapy

Study Officials

  • Paula Dr Jiménez Fonseca, MD-PhD

    Sociedad Española de Oncología Medica (SEOM)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Paula Dr Jiménez Fonseca, MD-PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2021

First Posted

July 12, 2021

Study Start

April 27, 2020

Primary Completion (Estimated)

December 1, 2034

Study Completion (Estimated)

December 1, 2035

Last Updated

July 3, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations